Unigestion Holding Sa Incyte Corp Transaction History

Unigestion Holding Sa

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $519,768 - $608,146	-8,206 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$79.87 - $87.53 $478,421 - $524,304	-5,990 Reduced 42.19%	8,206 $695,000
Q1 2021 May 05, 2021	SELL	$76.02 - $100.5 $439,395 - $580,890	-5,780 Reduced 28.93%	14,196 $1.15 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $65,237 - $78,941	808 Added 4.22%	19,976 $1.74 Million
Q3 2020 Nov 10, 2020	BUY	$85.07 - $109.69 $1.33 Million - $1.72 Million	15,662 Added 446.72%	19,168 $1.72 Million
Q2 2020 Aug 05, 2020	BUY	$74.18 - $108.93 $260,075 - $381,908	3,506 New	3,506 $365,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Unigestion Holding Sa with notifications on news.